In The News Posted March 1, 2019 Share Posted March 1, 2019 LE MONT-SUR-LAUSANNE, Switzerland, March 1, 2019 /PRNewswire/ -- In Europe, the Regen Lab group ("Regen") defends one of its patents (EP2073862B, method of PRP preparation) in opposition proceedings before the European Patent Office (EPO), where alleged patent infringers have contested... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.